BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marzagalli M, Moretti RM, Messi E, Marelli MM, Fontana F, Anastasia A, Bani MR, Beretta G, Limonta P. Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol. Sci Rep 2018;8:587. [PMID: 29330434 DOI: 10.1038/s41598-017-19057-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Wong SK, Kamisah Y, Mohamed N, Muhammad N, Masbah N, Fahami NAM, Mohamed IN, Shuid AN, Saad QM, Abdullah A, Mohamad NV, Ibrahim NI, Pang KL, Chow YY, Thong BKS, Subramaniam S, Chan CY, Ima-Nirwana S, Chin AK. Potential Role of Tocotrienols on Non-Communicable Diseases: A Review of Current Evidence. Nutrients 2020;12:E259. [PMID: 31963885 DOI: 10.3390/nu12010259] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
2 Limonta P, Queirolo P. New insights in melanoma biology: Running fast towards precision medicine. Semin Cancer Biol 2019;59:161-4. [PMID: 31562958 DOI: 10.1016/j.semcancer.2019.09.019] [Reference Citation Analysis]
3 Thyagarajan A, Tsai KY, Sahu RP. MicroRNA heterogeneity in melanoma progression. Semin Cancer Biol 2019;59:208-20. [PMID: 31163254 DOI: 10.1016/j.semcancer.2019.05.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
4 Fattore L, Mancini R, Ciliberto G. Cancer Stem Cells and the Slow Cycling Phenotype: How to Cut the Gordian Knot Driving Resistance to Therapy in Melanoma. Cancers (Basel) 2020;12:E3368. [PMID: 33202944 DOI: 10.3390/cancers12113368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Amalinei C, Grigoraș A, Lozneanu L, Căruntu I, Giușcă S, Balan RA. The Interplay between Tumour Microenvironment Components in Malignant Melanoma. Medicina 2022;58:365. [DOI: 10.3390/medicina58030365] [Reference Citation Analysis]
6 Fontana F, Raimondi M, Marzagalli M, Audano M, Beretta G, Procacci P, Sartori P, Mitro N, Limonta P. Mitochondrial functional and structural impairment is involved in the antitumor activity of δ-tocotrienol in prostate cancer cells. Free Radic Biol Med 2020;160:376-90. [PMID: 32738396 DOI: 10.1016/j.freeradbiomed.2020.07.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
7 Jasmer KJ, Hou J, Mannino P, Cheng J, Hannink M. Heme oxygenase promotes B-Raf-dependent melanosphere formation. Pigment Cell Melanoma Res 2020;33:850-68. [PMID: 32558263 DOI: 10.1111/pcmr.12905] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Kyriakou G, Melachrinou M. Cancer stem cells, epigenetics, tumor microenvironment and future therapeutics in cutaneous malignant melanoma: a review. Future Oncol 2020;16:1549-67. [PMID: 32484008 DOI: 10.2217/fon-2020-0151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Aggarwal V, Kashyap D, Sak K, Tuli HS, Jain A, Chaudhary A, Garg VK, Sethi G, Yerer MB. Molecular Mechanisms of Action of Tocotrienols in Cancer: Recent Trends and Advancements. Int J Mol Sci 2019;20:E656. [PMID: 30717416 DOI: 10.3390/ijms20030656] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 11.7] [Reference Citation Analysis]
10 Fontana F, Marzagalli M, Raimondi M, Zuco V, Zaffaroni N, Limonta P. δ-Tocotrienol sensitizes and re-sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK-mediated apoptosis. Cell Prolif 2021;54:e13111. [PMID: 34520051 DOI: 10.1111/cpr.13111] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Limonta P, Moretti RM, Marzagalli M, Fontana F, Raimondi M, Montagnani Marelli M. Role of Endoplasmic Reticulum Stress in the Anticancer Activity of Natural Compounds. Int J Mol Sci 2019;20:E961. [PMID: 30813301 DOI: 10.3390/ijms20040961] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 13.7] [Reference Citation Analysis]
12 Patinote C, Cirnat N, Hadj-Kaddour K, Cuq P, Bonnet PA, Deleuze-Masquéfa C. Substantial Cellular Penetration of Fluorescent Imidazoquinoxalines. J Fluoresc 2020;30:1499-512. [PMID: 32778995 DOI: 10.1007/s10895-020-02595-y] [Reference Citation Analysis]
13 DeWane ME, Shahriari N, Grant-Kels JM. Nutrition and melanoma prevention. Clin Dermatol 2021:S0738-081X(21)00224-8. [PMID: 34836731 DOI: 10.1016/j.clindermatol.2021.10.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yang CS, Luo P, Zeng Z, Wang H, Malafa M, Suh N. Vitamin E and cancer prevention: Studies with different forms of tocopherols and tocotrienols. Mol Carcinog 2020;59:365-89. [PMID: 32017273 DOI: 10.1002/mc.23160] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
15 Mukherjee N, Lambert KA, Norris DA, Shellman YG. Enrichment of Melanoma Stem-Like Cells via Sphere Assays. Methods Mol Biol 2021;2265:185-99. [PMID: 33704715 DOI: 10.1007/978-1-0716-1205-7_14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ruocco MR, Avagliano A, Granato G, Vigliar E, Masone S, Montagnani S, Arcucci A. Metabolic flexibility in melanoma: A potential therapeutic target. Semin Cancer Biol 2019;59:187-207. [PMID: 31362075 DOI: 10.1016/j.semcancer.2019.07.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
17 Fontana F, Raimondi M, Di Domizio A, Moretti RM, Montagnani Marelli M, Limonta P. Unraveling the molecular mechanisms and the potential chemopreventive/therapeutic properties of natural compounds in melanoma. Semin Cancer Biol 2019;59:266-82. [PMID: 31233829 DOI: 10.1016/j.semcancer.2019.06.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
18 Fontana F, Moretti RM, Raimondi M, Marzagalli M, Beretta G, Procacci P, Sartori P, Montagnani Marelli M, Limonta P. δ-Tocotrienol induces apoptosis, involving endoplasmic reticulum stress and autophagy, and paraptosis in prostate cancer cells. Cell Prolif 2019;52:e12576. [PMID: 30719778 DOI: 10.1111/cpr.12576] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 7.7] [Reference Citation Analysis]
19 Oswald JT, Patel H, Khan D, Jeorje NN, Golzar H, Oswald EL, Tang S. Drug Delivery Systems Using Surface Markers for Targeting Cancer Stem Cells. Curr Pharm Des 2020;26:2057-71. [PMID: 32250211 DOI: 10.2174/1381612826666200406084900] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Aykin-Burns N, Pathak R, Boerma M, Kim T, Hauer-Jensen M. Utilization of Vitamin E Analogs to Protect Normal Tissues While Enhancing Antitumor Effects. Semin Radiat Oncol 2019;29:55-61. [PMID: 30573184 DOI: 10.1016/j.semradonc.2018.10.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
21 Elgendy SM, Alyammahi SK, Alhamad DW, Abdin SM, Omar HA. Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance. Crit Rev Oncol Hematol 2020;155:103095. [PMID: 32927333 DOI: 10.1016/j.critrevonc.2020.103095] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
22 Hüser L, Altevogt P, Utikal J. Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies. Oncotarget 2019;10:1662-3. [PMID: 30899437 DOI: 10.18632/oncotarget.26718] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Matias M, Pinho JO, Penetra MJ, Campos G, Reis CP, Gaspar MM. The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval. Cells 2021;10:3088. [PMID: 34831311 DOI: 10.3390/cells10113088] [Reference Citation Analysis]
24 Diana A, Gaido G, Maxia C, Murtas D. MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies. Int J Mol Sci 2020;21:E9630. [PMID: 33348804 DOI: 10.3390/ijms21249630] [Reference Citation Analysis]
25 Fontana F, Raimondi M, Marzagalli M, Moretti RM, Marelli MM, Limonta P. Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents. Recent Pat Anticancer Drug Discov 2019;14:5-18. [PMID: 30652648 DOI: 10.2174/1574892814666190116111827] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
26 Fontana F, Limonta P. The multifaceted roles of mitochondria at the crossroads of cell life and death in cancer. Free Radic Biol Med 2021;176:203-21. [PMID: 34597798 DOI: 10.1016/j.freeradbiomed.2021.09.024] [Reference Citation Analysis]
27 Montagnani Marelli M, Marzagalli M, Fontana F, Raimondi M, Moretti RM, Limonta P. Anticancer properties of tocotrienols: A review of cellular mechanisms and molecular targets. J Cell Physiol 2019;234:1147-64. [PMID: 30066964 DOI: 10.1002/jcp.27075] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
28 Mukherjee N, Skees J, Todd KJ, West DA, Lambert KA, Robinson WA, Amato CM, Couts KL, Van Gulick R, MacBeth M, Nassar K, Tan AC, Zhai Z, Fujita M, Bagby SM, Dart CR, Lambert JR, Norris DA, Shellman YG. MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells. Cell Death Dis 2020;11:443. [PMID: 32513939 DOI: 10.1038/s41419-020-2646-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
29 Tham SY, Loh HS, Mai CW, Fu JY. Tocotrienols Modulate a Life or Death Decision in Cancers. Int J Mol Sci 2019;20:E372. [PMID: 30654580 DOI: 10.3390/ijms20020372] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
30 Marzagalli M, Raimondi M, Fontana F, Montagnani Marelli M, Moretti RM, Limonta P. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications. Semin Cancer Biol 2019;59:221-35. [PMID: 31265892 DOI: 10.1016/j.semcancer.2019.06.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
31 Mukherjee N, Amato CM, Skees J, Todd KJ, Lambert KA, Robinson WA, Van Gulick R, Weight RM, Dart CR, Tobin RP, McCarter MD, Fujita M, Norris DA, Shellman YG. Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma. Cancers (Basel) 2020;12:E2182. [PMID: 32764384 DOI: 10.3390/cancers12082182] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
32 Raimondi M, Fontana F, Marzagalli M, Audano M, Beretta G, Procacci P, Sartori P, Mitro N, Limonta P. Ca2+ overload- and ROS-associated mitochondrial dysfunction contributes to δ-tocotrienol-mediated paraptosis in melanoma cells. Apoptosis 2021;26:277-92. [PMID: 33811561 DOI: 10.1007/s10495-021-01668-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Marzagalli M, Fontana F, Raimondi M, Limonta P. Cancer Stem Cells-Key Players in Tumor Relapse. Cancers (Basel) 2021;13:376. [PMID: 33498502 DOI: 10.3390/cancers13030376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]